Cardio-Metabolic

Cardio-Metabolic includes companies targeting cardiovascular disease, obesity, diabetes, lipid disorders, and related metabolic conditions. This page highlights businesses exposed to some of the largest and most competitive treatment categories in biotech and pharma.

Why watch Cardio-Metabolic

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Cardio-Metabolic news

The latest feed items from companies currently grouped under Cardio-Metabolic.

1. 01
   2026-08-07 10:30 EST

   EMBCEmbecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

   Source: Embecta

2. 02
   2026-08-07 10:00 EST

   EMBCembecta Announces Quarterly Cash Dividend

   Source: Embecta

3. 03
   2026-08-06 20:05 EST

   CVRXCVRx Reports Second Quarter 2026 Financial and Operating Results

   Source: CVRx

4. 04
   2026-08-06 20:01 EST

   NAMSNewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

   Source: NewAmsterdam Pharma

5. 05
   2026-08-06 20:01 EST

   SENSSenseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results

   Source: Senseonics

6. 06
   2026-08-06 12:00 EST

   ALGSAligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

   Source: Aligos Therapeutics

7. 07
   2026-08-06 12:00 EST

   VANIVivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

   Source: Vivani Medical

8. 08
   2026-08-06 12:00 EST

   BLTEBelite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results

   Source: Belite Bio

9. 09
   2026-08-06 11:30 EST

   LXRXLexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

   Source: Lexicon Pharmaceuticals

10. 10
    2026-08-05 20:01 EST

    MNKDMannKind Reports Second Quarter 2026 Financial Results and Provides Business Update

    Source: MannKind

11. 11
    2026-08-05 12:00 EST

    ALTAltimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

    Source: Altimmune

12. 12
    2026-08-05 11:00 EST

    NAMSNewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results

    Source: NewAmsterdam Pharma

13. 13
    2026-08-04 20:01 EST

    RYTMRhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

    Source: Rhythm Pharmaceuticals

14. 14
    2026-08-04 20:01 EST

    MISTMilestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026

    Source: Milestone Pharmaceuticals Inc.

15. 15
    2026-08-04 12:00 EST

    MLYSMineralys Therapeutics to Announce Second Quarter 2026 Financial Results and Host Conference Call on Tuesday, August 11, 2026

    Source: Mineralys Therapeutics

16. 16
    2026-08-04 11:01 EST

    RYTMRhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

    Source: Rhythm Pharmaceuticals

17. 17
    2026-08-04 11:00 EST

    SGMTSagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference

    Source: Sagimet Biosciences

18. 18
    2026-08-04 10:55 EST

    RYTMRhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

    Source: Rhythm Pharmaceuticals

19. 19
    2026-08-03 12:00 EST

    ALTAltimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH

    Source: Altimmune

20. 20
    2026-07-30 12:30 EST

    LXRXLexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

    Source: Lexicon Pharmaceuticals

Companies in Cardio-Metabolic

35 companies tagged with Cardio-Metabolic.

Frequently Asked Questions